[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366390-105":59,"doc-detail-366390-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exosomal-long-non-coding-rnas-in-gastrointestinal-cancer-chemoresistance-mediators-and-therapeutic-targets","Exosomal long non-coding RNAs in gastrointestinal cancer - chemoresistance mediators and therapeutic targets","","Gastrointestinal (GI) cancer comprises malignant tumors that affect the GI tract, with chemotherapy serving as a main treatment option, particularly in advanced disease. Chemoresistance, however, undermines treatment success by reducing efficacy, worsening clinical outcomes, and increasing metastatic potential. Long non-coding RNAs (lncRNAs) can be packaged into exosomes, enabling intercellular communication and the transfer of chemoresistance traits. This review summarizes exosomal lncRNA biogenesis and their functional roles in promoting chemoresistance across GI cancer types, highlighting key lncRNAs, mechanisms, and therapeutic strategies to target these molecules and improve treatment effectiveness.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exosomal-long-non-coding-rnas-in-gastrointestinal-cancer-chemoresistance-mediators-and-therapeutic-targets/366390/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exosomal-long-non-coding-rnas-in-gastrointestinal-cancer-chemoresistance-mediators-and-therapeutic-targets/366390.png","ImageObject",300,407,{"name":92,"@type":93},"supergirl","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is chemoresistance a major problem in gastrointestinal cancer treatment?","Question",{"text":112,"@type":113},"Chemoresistance makes cancer cells unresponsive to chemotherapy, reducing treatment efficacy and worsening patient outcomes. It can also increase toxicity by driving the need for alternative therapies or higher drug doses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do exosomal long non-coding RNAs contribute to chemoresistance?",{"text":117,"@type":113},"Recent research shows lncRNAs can be packaged into exosomes, which support intercellular communication. Transferred exosomal lncRNAs can help spread chemoresistance traits among cancer cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review cover regarding therapeutic targeting?",{"text":121,"@type":113},"The review highlights specific exosomal lncRNAs, explains their mechanisms of action, and discusses innovative therapeutic strategies aimed at targeting these molecules. It also frames exosomal lncRNAs as potential biomarkers for liquid biopsies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366390,1790319640,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Li et al. Journal of Translational Medicine (2025) 23:889  \n[https://doi.org/10.1186/s12967-025-06878-5](https://doi.org/10.1186/s12967-025-06878-5)  \nJournal of Translational Medicine  \n REVIEW Open Access  \nExosomal long non-coding RNAsin gastrointestinal cancer: chemoresistance mediators and therapeutic targets  \nChenhe Li1†, Shunjia Xing1†, Dechun Zhang1, Ruoyu Li1, Qian Li2, Hongliang Luo3* and Fangteng Liu3*  \nAbstract  \nGastrointestinal (GI) cancer is a series of malignant cancer mainly affecting the GI tract. Chemotherapy is oneof the most treatment strategies used in GI cancer treatment, especially in advanced cases. However, the challenge of chemoresistance significantly compromises treatment success, resulting in poorer clinical outcomes and increased metastatic potential. Long non-coding RNAs (lncRNAs) have emerged as important regulators of gene expression and are implicated in various disease processes. Recent research has demonstrated that lncRNAs can be packaged within exosomes, thereby facilitating intercellular communication and potentially transferring chemoresistance traits among cancer cells. This review focuses on the biogenesis and functional roles of exosomal lncRNAs in promoting chemoresistance across different GI cancers. We highlight specific lncRNAs, elucidate their mechanisms of action, and discuss innovative therapeutic strategies aimed at targeting these molecules in gastrointestinal malignancies. By exploring these intricate interactions, we aim to identify novel approaches to overcome chemoresistance and improve the efficacy of treatments for GI cancer.  \nKeywords Gastrointestinal cancers, Exosomal lncRNAs, Intercellular communication, Chemoresistance, Therapeutic targets  \n†Chenhe Li, Shunjia Xing have contributed equally to this work.  \n*Correspondence: Hongliang Luo[ndefy13028@ncu.edu.cn](ndefy13028@ncu.edu.cn)[ ](ndefy13028@ncu.edu.cn)Fangteng Liu [15807031758@163.com](15807031758@163.com)  \n1 Department of Clinical Medicine, School of Queen Mary, Nanchang University, Jiangxi 330006, People’s Republic of China  \n2 Department of Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, PR China  \n3 Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330008, Jiangxi, China  \nIntroduction  \nGastrointestinal (GI) cancers, including those of the esophagus, stomach, pancreas, colon, hepatic and rectum, are among the most prevalent and deadly malignancies globally. These cancers exhibit diverse pathogenic mechanisms, complicating treatment approaches [1]. Chemotherapy is a cornerstone of treatment, particularly for advanced GI cancers, where metastasis or surgical limitations necessitate systemic interventions. A critical challenge in the treatment of GI cancers is the development of chemoresistance, where cancer cells become unresponsive to chemotherapy. This reduces treatment efficacy and worsens patient outcomes [2]. Chemoresistance often leads to the need for alternative therapies or higher drug doses, increasing toxicity. It can be intrinsic or acquired, driven by various factors such as drug efflux mechanisms, altered drug  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission","cbCaioGeObXheqrw","https://ap.wps.com/l/cbCaioGeObXheqrw","pdf",1973550,23,"English","# Abstract\n# Keywords\n# Introduction\n## Chemotherapy and chemoresistance in GI cancers\n## lncRNAs and exosomes as regulators and messengers\n## Exosomal lncRNAs as mediators and therapeutic targets","[{\"question\":\"Why is chemoresistance a major problem in gastrointestinal cancer treatment?\",\"answer\":\"Chemoresistance makes cancer cells unresponsive to chemotherapy, reducing treatment efficacy and worsening patient outcomes. It can also increase toxicity by driving the need for alternative therapies or higher drug doses.\"},{\"question\":\"How do exosomal long non-coding RNAs contribute to chemoresistance?\",\"answer\":\"Recent research shows lncRNAs can be packaged into exosomes, which support intercellular communication. Transferred exosomal lncRNAs can help spread chemoresistance traits among cancer cells.\"},{\"question\":\"What does the review cover regarding therapeutic targeting?\",\"answer\":\"The review highlights specific exosomal lncRNAs, explains their mechanisms of action, and discusses innovative therapeutic strategies aimed at targeting these molecules. It also frames exosomal lncRNAs as potential biomarkers for liquid biopsies.\"}]","Exosomal long non-coding RNAs in gastrointestinal cancer - chemoresistance mediators and therapeutic targets | PDF",1790165214,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c471ea3d43c1fca5b4097f43b6ec91dc.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d58605fc21ebacdaea52e4a3b55fb5ca.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/790f8d12a15dbad786e0c015c3a9672f.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cfd81b0faa6c78e930b8b1974bb2f4a.webp",980,1301]